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Abstract 
Screening is seen by many as a key element in cancer control strategies. Differences in 
uptake of screening related to socioeconomic status exist and may contribute to differences in 
morbidity and mortality across socioeconomic groups. While a number of factors are likely to 
underlie differential uptake, differential access to subsequent diagnostic tests and/or treatment 
may have a pivotal role. This study examines differences in the uptake of cancer screening in 
Ireland related to socioeconomic status. Data were extracted from SLÁN 2007 concerning 
uptake of breast, cervical, colorectal and prostate cancer screening in the preceding 12 
months. Concentration indices were calculated by socioeconomic grouping and decomposed 
to identify the contribution to differential uptake of a range of variables. Particular emphasis 
was placed upon the impact of private health insurance, evidenced in other work to impact on 
access to care within the mixed public-private Irish health system. This study found that 
significant differences related to socioeconomic status exist with respect to uptake of cancer 
screening and that the main determinant of difference for breast, colorectal and prostate 
cancer screening was possession of private insurance. This may have profound implications 
for the design of cancer control strategies in countries where private insurance has a 
significant role, even where screening services are publicly funded and population-based.   
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1. Introduction 
The mixed public-private health care system that operates in the Republic of Ireland provides 
a complex environment within which services are delivered and accessed. Within the Irish 
system, those without a medical card (entitlement to which, at the time of this study, was 
means-tested in those under 70 and universal in those 70 and older), must pay a contribution 
for visiting primary care physicians and for hospital inpatient stays (approx €60 per 
visit/night) as well as the full costs of prescription medications (HSE, 2009). Most hospitals, 
including public hospitals, offer private care and at any stage, patients can transfer from 
public to private care. Approximately 30% of the population have a medical card and just 
under half have private health insurance. (Wiley, 2005)  
 
Previous work using concentration indices (Kakwani et al, 1997) has demonstrated a pro-
poor pattern of utilization (Layte and Nolan, 2004) with respect to primary care services in 
Ireland. This may be explained by the fact that the poorest third of the population (and those 
aged 70 and over) hold medical cards (Nolan 2007). By contrast pro-rich patterns of 
utilization have been observed with respect to specialist care services (Layte and Nolan, 
2004) where waiting lists in the public system exist and 20% of public hospitals’ capacity 
remains reserved for private patients (Wiley 2005).  
 
Decomposition analyses of social inequalities in other contexts have shown that much of the 
inequality in the utilisation of specialist services may relate to the operation of mixed public-
private healthcare wherein possession of insurance or private payments may afford faster 
access to care (Van Doorslaer et al., 2004b, Van Doorslaer et al., 2008). Possession of 
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insurance, however, may impact not only on the decision to access services to which 
differential entitlements exist but because of the integrated nature of healthcare they may also 
impact on the decision to access services where entitlements are supposedly the same. For 
example, with respect to cancer screening, in as much as the value of a screen is conditional 
on subsequent access to diagnostic and treatment services, the absence of insurance may 
attenuate the benefits of screening for those without insurance even where the screen itself is 
publicly funded.  
 
Research from other healthcare systems, in which access to services relate to possession of 
private health insurance, has identified insurance as one of the main determinants of cancer 
screening utilisation (Swan et al., 2010, Weber et al., 2008). In Ireland only for breast cancer 
is a publicly funded population-based programme fully operational in line with EU Council 
recommendations (EU Council 2003). While a population-based cervical cancer screening 
programme was established in late 2008, this has not yet been fully rolled out. In this context 
it is perhaps unsurprising that there has been a paucity of research regarding cancer screening 
uptake in Ireland or variations in uptake across socio-demographic groups. Previous research 
has found significant socioeconomic variations in the uptake of breast and cervical cancer 
screening, variations that were not present in other jurisdictions (Walsh et al., 2010, Walsh et 
al., 2011a). 
 
In this study we examine the extent of socioeconomic inequality across a number of 
screening services available in the Republic of Ireland using concentration indices. We 
decompose the indices to examine the role of insurance in this inequality. This, to the best of 
our knowledge, is the first time a decomposition analysis of a particular specialist service, 
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cancer screening, has been undertaken in a European context. While the focus of the study is 
on the Irish experience in respect of cancer screening, the insights with respect to use of 
specialist services are pertinent to healthcare services and systems generally where 
entitlements vary.  
 
2. Methods 
Data Analysis 
Data were extracted from SLÁN 2007 - a large representative, cross-sectional survey of 
health and wellbeing conducted using face-to-face interviews with 10,364 adults. Individual-
based data were collected on a range of issues, including for the first time in Ireland, data on 
uptake of breast, prostate, colorectal and cervical cancer screening in the preceding 12 
months. Details of the dataset are also discussed extensively elsewhere (Walsh et al., 2010, 
Morgan et al., 2008). Included in the dataset are a range of socioeconomic variables that 
allow for a detailed socio-demographic characterization of the respondent. Data on 1203 
women aged 50-64, (the age range targeted by the national breast cancer screening 
programme) and 3937 women aged 25-64 (the age range targeted by the national cervical 
programme) were extracted. Data on 3066 individuals aged 50-74 and 1404 men aged 50-74 
were extracted with respect to colorectal and prostate cancer screening respectively. No 
population-based screening programmes operate in the Republic of Ireland for the latter two 
cancers but the age ranges specified reflect those used in other programmes or recommended 
by the EU Council (Schroder et al., 2009, Advisory Committee on Cancer Prevention, 2000). 
Net equivalised household income, household socioeconomic status (based on occupation), 
geographic location, age, marital status, insurance coverage and self reported health were 
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used in the decomposition analyses based upon their anticipated impact on screening 
utilisation. 
 
Concentration indices 
Equivalised net household income was used as the ranking variable in the construction of the 
concentration indices1. Income was recorded as 25 categories in the survey, with class 
midpoint used as the income level for each group. Chen et al. (2009) have shown that 
grouped income data may lead to an underestimation of the concentration index. But the 
extensive number of income categories used here together with the subsequent use of an 
equivalence scale allows for within group variation thus mitigating any underestimation in 
the resultant concentration indices. Following Kakwani et al. (1997) and Van Doorslaer et al. 
(1997) the concentration index is presented as equation 1.2  
 
As in our analyses the dependent variable was a binary response (whether individuals had a 
screen in the previous 12 months or not), normalised concentration indices of screening 
utilisation and fractional rank of income were calculated using the binary variable method in 
Wagstaff (2005).3   
                                                          
1
 Total household income is divided by an equivalence scale which takes the value 1 for the first adult in the 
household, 0.66 for any subsequent adults and 0.33 for each child. This scale has been used in previous research 
by Layte and Nolan (2004). 
2
 In equation 1  is the health variable (whether an individual had a cancer screen in the preceding 12 months) 
which has been distributed according to socioeconomic status from lowest to highest group. µ  is the mean of our 
health variable.  is the fractional rank of the ith individual within the socioeconomic distribution. Thus CI 
measures relative inequality across the socioeconomic distribution with a positive result reflecting a pro-rich 
inequality. 
3
 Normalisation of the concentration indices using methods put forth by Erreygers (2009) were also undertaken, 
with results similar to those produced using Wagstaff (2005) methods. 
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Decomposition analyses of the overall inequality thus allow us to establish the importance of 
particular components of the inequality in screening uptake by partitioning total inequality 
into the specific inequalities observed by each individual regressor. Hence the decomposition 
allows for the unpacking of the variables that contribute to the level of inequality and permits 
a clearer identification of possible policy instruments (Van Doorslaer et al., 2004a). As the 
likelihood of uptake is intrinsically a non-linear relationship our analyses are based upon a 
logistic model. Within our statistical analyses, the logistic regression was shown to have the 
most explanatory power of the regression approaches. In order for a decomposition to take 
place a linear approximation is thus needed. An average partial effects approach, following 
the logistic regression is used for the decomposition whereby , the sample mean within 
each group, is the average partial effects for each determinant x. This approach allows for the 
decomposition of the main determinants underpinning any inequalities. 
 
 
 
In equation 4, the first expression represents the contribution of equivalised income, the 
second expression represents the other socioeconomic variables perceived to influence 
screening utilisation while the final expression represents the residual term. 
 
 
8 
 
3. Results 
Table I provides descriptive statistics that highlight variations in screening utilisation across 
socioeconomic groups. Those with higher income, higher socioeconomic status and higher 
educational attainment have greater uptake for all types of screening. The largest difference is 
observed between those with and without medical insurance. Uptake of cervical (18%) and 
colorectal (12%) cancer screening is seen to be lower than that for the other types of cancer. 
The high uptake of prostate (29%) cancer screening may be noteworthy given concerns 
regarding the value of untargeted and repeat screening for this cancer.  
 
The normalised concentration indices in Table II demonstrate significant socioeconomic 
inequality in cancer screening uptake in the Republic of Ireland. While the largest inequality 
is observed for prostate cancer screening (0.1444), it is notable that inequality observed for 
breast cancer screening (0.1229), which was part of a publicly funded population-based 
programme at this time, is large. Concentration indices for breast (0.1229), cervical (0.1014), 
colorectal (0.0695) and prostate (0.1444) cancer were all found to be statistically significant 
at the 95% level. It has been stated that a concentration index of 0.1 corresponds to a relative 
rate of approximately 2 and has significant implications for health policy (Webb et al., 2005). 
These results show that for three of the cancers, the socioeconomic inequalities observed may 
lead to significant public health issues. 
 
The decomposition of the concentration indices are shown in Table III. While differences 
across socioeconomic group is the largest determinant of inequality observed for cervical 
cancer, insurance is the largest determinant for breast, colorectal and prostate cancer 
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screening, contributing 22%, 60% and 39% of the inequality respectively. In the interests of 
brevity, differences across age, geographic location and other variables are not discussed in 
this study. 
 
4. Conclusion 
The diagnosis and treatment of many conditions involves primary, secondary and tertiary 
level services working together. Even when access to parts of a system are, in the interests of 
equity, publicly funded and/or provided, if the effectiveness of any one part is contingent 
upon access to other parts to which insurance affords differential access, publically funded 
services may fail to eradicate inequalities at all levels. More generally if the speed with which 
a patient moves along any part of a care pathway can be expedited by private insurance, 
differences in patterns of utilization are likely to manifest themselves throughout the care 
pathway. These differences may ultimately initiate differential health outcomes and may be 
more evident for some cancers than others, for example, in cervical cancer where incidence is 
higher among lower socioeconomic groups (Kahn et al., 2007).  
 
This study demonstrates inequality in the uptake of cancer screening in the Republic of 
Ireland and the role of private medical insurance in this. The results extend the findings of 
previous studies where the largest pro-rich inequalities in specialist care utilisation were 
observed in health systems, including Ireland, whereby the provision of secondary services 
was at least partially contingent upon private insurance and/or out-of pocket payments  
(Layte and Nolan 2004, Van Doorslaer et al., 2004a, Jones et al., 2006). With respect to 
breast cancer, that a population-based screening programme had been established at the time 
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of the survey (though not fully implemented), is noteworthy given the large inequality 
observed here (0.1229). Whether inequalities reduce as this programme matures remains to 
be seen (Walsh et al., 2011b) but that establishment of a state-funded programme per-se will 
not eliminate inequalities in screening utilisation is evident.  
 
This study highlights that in the case of three of the cancers considered; possession of 
insurance is the central determinant to inequalities in uptake. Work by Kenkel (1994) has 
shown that insurance coverage for curative care encourages the use of screening as the earlier 
detection of a cancer is only valuable in the presence of earlier treatment interventions. While 
access to diagnostics and treatment may be more equitable in the case of breast cancer where 
arrangements for this have been made as part of the population-based screening initiative, as 
has been shown in the Republic of Ireland the perception may still remain that having 
insurance has a role to play in diagnosis and treatment (Harmon and Nolan, 2001). That those 
who hold private insurance may attach a higher value to health or possess a greater 
knowledge of how to use the healthcare system is possible and could offer an alternative 
explanation for the results. Given the work of Harmon and Nolan (2001) and O’Malley et al 
(2004) it would though be perverse to argue that the differential access insurance affords does 
not have a role in inequalities and is not acquired because of this.   
 
Unless and until access to subsequent diagnosis and care is as equitable as access to 
population-based screening programme, these results may be replicated in each of the other 
cancers, and may survive the introduction of publicly funded population-based screening 
services and be replicated in other parts of the system and be observed in other healthcare 
systems.  
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Table I Percentage uptake of cancer screening in Ireland in preceding 12 months. 
 
 
Observations 
Breast Cancer 
Screening % 
1203 
Cervical Cancer 
Screening % 
3937 
Colorectal Cancer 
Screening % 
3066 
Prostate Cancer 
Screening % 
1404 
 
Total % 
 
 
33.92 
 
17.98 
 
11.53 
 
29.47 
Socioeconomic 
Group 
SES1 
 
 
40.25 
 
 
22.63 
 
 
14.93 
 
 
36.94 
SES2 33.33 17.83 12.23 32.50 
SES3 30.95 17.16 9.53 26.01 
SES4 29.89 11.76 10.25 22.36 
SES5 
 
29.81 14.87 5.08 23.81 
Education 
Degree or above 
 
40.94 
 
21.64 
 
11.97 
 
34.85 
Lower tertiary 40.11 20.70 13.73 43.36 
Upper secondary 35.93 17.76 13.98 31.88 
Lower secondary 27.7 13.36 9.25 21.48 
Primary 
 
30.28 12.69 10.55 25.91 
Insurance 
Yes 
 
38.04 
 
20.54 
 
13.57 
 
36.34 
No 
 
27.87 14.57 8.84 20.08 
Marital Status 
Married 
 
34.86 
 
19.16 
 
12.51 
 
33.67 
Not Married 
 
31.82 15.53 9.72 21.46 
Geographic location 
Dublin 
 
41.58 
 
17.86 
 
12.85 
 
30.60 
Border 29.41 16.87 7.84 21.05 
Mid-East 56.54 19.75 10.08 18.45 
Midlands 38.81 23.46 19.25 40.00 
Mid-West 18.28 21.22 10.42 25.19 
South East 36.18 18.50 14.07 37.50 
South West 20.00 15.08 8.60 32.02 
West 
 
21.15 14.33 12.24 28.44 
Age 
25-29 years 
 
- 
 
16.34 
 
- 
 
- 
30-34 years - 18.56 - - 
35-39 years - 18.89 - - 
40-44 years - 17.79 - - 
45-49 years - 21.03 - - 
50-54 years 30.64 18.49 9.07 23.08 
55-59 years 34.24 16.07 11.01 28.32 
60-64 years 37.64 15.03 13.94 34.34 
65-69 years - - 12.61 35.68 
70-74 years 
 
- - 13.04 27.03 
Self reported Health 
Good 
 
 
33.13 
 
 
17.65 
 
 
10.56 
 
 
30.37 
Bad 
 
37.50 21.04 15.12 26.71 
Gender 
Male 
 
- 
 
- 
 
14.67 
 
- 
Female - - 8.99 - 
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Table II: Concentration Indices of cancer screening utilisation and socio-economic inequality 
 Breast cancer 
screening 
Cervical cancer 
screening 
Colorectal cancer 
screening 
Prostate cancer 
screening 
 
Concentration index 
 
Standard error 
 
T value 
 
0.1229 
 
0.0377 
 
3.26 
 
0.1014 
 
0.0261 
 
3.88 
 
0.0695 
 
0.0352 
 
1.99 
 
0.1444 
 
0.0350 
 
4.12 
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Table III: Decomposition of concentration index of socioeconomic inequality gradient.#* 
 Breast Cancer 
Screening (%) 
Cervical Cancer 
Screening (%) 
Colorectal Cancer 
Screening (%) 
Prostate Cancer 
Screening (%) 
CI (Actual) 0.1229  0.1014  0.0695  0.1444  
CI (Predicted) 0.0831 0.0780 0.0584 0.1010 
GCI(Residual) 0.0398 0.0234 0.0111 0.0434 
Ln(income) 
 
0.0189 (15.4)  0.0155 (15.3) 0.0116 (16.7) 0.0317 (21.9) 
Socioeconomic Group 
SES 1 
 
0 
 
0 
 
0 
 
0 
SES 2 -0.0005 (0.4) 0.0005 (0.4)  0.0003 (0.4) 0.0002 (0.1) 
SES 3 0.0017 (1.3) 0.0033 (3.1) 0.0016 (2.2) 0.0037 (2.6) 
SES 4 0.0108 (8.8) 0.0388 (38.3) 0.0059 (8.6) 0.0144 (10.0) 
SES 5 
 
0.0077 (6.3) 0.0057 (5.5) 0.0068 (9.7) 0.0012 (0.08) 
Insurance 
 
0.0261 (21.8) 0.0038 (3.8) 0.0417 (60.0) 0.0565 (39.1) 
Education 
Degree or above 
 
0 
 
0 
 
0 
 
0 
Lower tertiary 0.0014 (1.2)  0.0010 (0.9) 0.0052 (7.5) 0.0017 (1.2) 
Upper secondary -0.0011 (1.0) 0.0006 (0.5) 0.0035 (5.1) 0.0003 (0.2) 
Lower secondary 0.0094 (7.7) 0.0116 (12.0) 0.0027 (3.9) 0.0049 (3.4) 
Primary 
 
0.0098 (8.0) 0.0074 (7.4) -0.0027 (-3.4) -0.0022 (-1.5) 
Married 
 
0.0007 (0.6) 0.0041 (4.0) 0.0048 (7.0) 0.0078 (5.4) 
Geographic location 
Dublin 
 
0 
 
0 
 
0 
 
0 
Border 0.0035 (2.9) -0.0009 (-0.9) 0.0065 (9.3) 0.0059 (4.1) 
Mid-East 0.0025 (2.1) -0.0003 (-0.4) -0.0033 (-4.7) -0.0032 (-2.2) 
Midlands 0.0002 (0) -0.0010 (-1.0) -0.0009 (-1.2) 0.0004 (0.3) 
Mid-West 0.0029 (2.4) -0.0008 (-0.9) 0.0003 (0.4) -0.0002 (-0.2) 
South East 0.0025 (2.0) 0.0001 (0.1) -0.0001 (-0.1) -0.0010 (-0.7) 
South West 0.0015 (1.3) -0.0007 (-0.6) 0.0009 (1.3) -0.0000 (0.0) 
West 
 
-0.0016 (-1.3) 0.0002 (0.2) -0.0001 (-0.1) -0.0006 (-0.4) 
Age Categories     
25-29 years - 0.0004 (0.4) - - 
30-34 years - 0.0011 (1.1) - - 
35-39 years - 0.0007 (0.7) - - 
40-44 years - -0.0001 (-0.1) - - 
45-49 years  - -0.0008 (-0.8) - - 
50-54 years -0.0040 (-3.2) 0.0000 (0.0) -0.0125 (-17.9) -0.0119 (-8.2) 
55-59 years -0.0017 (-1.4) 0.0002 (0.2) -0.0050 (-7.1) -0.0010 (-0.7) 
60-64 years 0 0 0 0 
65-69 years - - 0.0043 (6.1) -0.0009 (-0.6) 
70-74 years 
 
- - 0.0009 (1.4) -0.0012 (-0.8) 
Self reported health 
 
-0.0078 (-6.3) -0.0127 (-12.7) -0.0243 (-40.0) -0.0056 (-3.9) 
Female - - 0.0103 (14.8) - 
# Results represented as contributions with percentage contribution in brackets. 
*Elasticities and concentration indices were each regressor were also produced but are not discussed in the results. 
 
